<DOC>
	<DOCNO>NCT01769638</DOCNO>
	<brief_summary>This study investigate safety pharmacokinetic comparison Seoul Pharma 's orally disintegrating film ( ODF ) formulation sildenafil ( test formulation ) Pfizer 's `` ViagraÂ® ( sildenafil ) '' Film Coated Tablet ( FCT ) formulation ( reference formulation ) healthy volunteer .</brief_summary>
	<brief_title>Safety Pharmacokinetic Comparison Sildenafil ODF FCT Formulations Healthy Korean Volunteers</brief_title>
	<detailed_description>- Background : An orally disintegrating film ( ODF ) formulation sildenafil recently develop Korea . This formulation expect enhance dose convenience increase patient compliance yield pharmacokinetic profile comparable conventional film coat tablet ( FCT ) formulation . - Objective : The goal present study compare pharmacokinetic ( PK ) profile newly develop ODF formulation FCT formulation sildenafil healthy Korean male volunteer . - Methods : This randomize , open-label , 2-period cross-over , single-dose study conduct 2 part . Eligible subject healthy male volunteer age 20 50 year within 20 % ideal body weight , equally divide part 1 2 . Each subject receive single -dose ODF FCT formulation sildenafil orally fast state ( part 1 , 50mg ; part 2 , 100mg ) , 7-day washout period formulation . Blood sample collect 24 hour . Pharmacokinetic parameter determine sildenafil active metabolite ( N-desmethyl sildenafil ) . Adverse event also evaluate base subject interview physical examination .</detailed_description>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Eligible subject healthy male volunteer age 20 50 year within 20 % ideal body weight , With congenital abnormality chronic disease . Key exclusion criterion include : history cardiovascular , pulmonary , renal , endogenous , gastrointestinal , hematologic , neurologic , hemorrhagic disease ; anatomical abnormality penis factor cause priapism ( e.g. , sicklemia , multiple myeloma , leukemia ) ; clinically significant finding routine laboratory ( serology , hematology , serum chemistry , urinalysis ) , ECG color blindness test [ 8 , 16 ] ; history hypersensitivity reaction PDE5 inhibitor include sildenafil ; use prescription drug within 14 day study potential interact study medication ; use substance could induce inhibit cytochrome P450 3A4 synthesis ( eg , St. John 's wort , herbal medication ) .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Orally disintegrate Film</keyword>
	<keyword>Film Coated Tablet</keyword>
	<keyword>Sildenafil</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>